• wonderlic tests
  • EXAM REVIEW
  • NCCCO Examination
  • Summary
  • Class notes
  • QUESTIONS & ANSWERS
  • NCLEX EXAM
  • Exam (elaborations)
  • Study guide
  • Latest nclex materials
  • HESI EXAMS
  • EXAMS AND CERTIFICATIONS
  • HESI ENTRANCE EXAM
  • ATI EXAM
  • NR AND NUR Exams
  • Gizmos
  • PORTAGE LEARNING
  • Ihuman Case Study
  • LETRS
  • NURS EXAM
  • NSG Exam
  • Testbanks
  • Vsim
  • Latest WGU
  • AQA PAPERS AND MARK SCHEME
  • DMV
  • WGU EXAM
  • exam bundles
  • Study Material
  • Study Notes
  • Test Prep

Week 4 Midterm: NR565 NR-565

QUESTIONS & ANSWERS Dec 16, 2025 ★★★★★ (5.0/5)
Loading...

Loading document viewer...

Page 0 of 0

Document Text

Week 4 Midterm: NR565 / NR-565

(Latest Update 2025 / 2026) Advanced Pharmacology Fundamentals | Test Module Questions & Answers | 100% Correct | Grade A - Chamberlain

Question:

Marilyn has a bone density study completed. Findings indicate osteoporosis with a T-score of −2.8 at the femoral neck and spine. Which of the following is the best treatment option for Marilyn?

a) Calcium and vitamin D supplementation

b) Bisphosphonate medication alone

c) Levothyroxine

d) Calcium and vitamin D supplementation and a bisphosphonate

Answer:

Calcium and vitamin D supplementation and a bisphosphonate (Correct answer) 1 / 2

Question:

Calcium supplementation varies with age. Current recommendations include:

  • adolescents 1300 mg daily; young adults; 1200 mg daily; older adults 1000
  • mg daily

  • adolescents 1000 mg daily; young adults 1200 mg daily; older adults 1300
  • mg daily

  • adolescents 1200 mg daily; young adults 1000 mg daily; older adults 1300
  • mg daily

  • adolescents 1300 mg daily; young adults 1000 mg daily; older adults 1200
  • mg daily

Answer:

adolescents 1300 mg daily; young adults 1000 mg daily; older adults 1200 mg daily

Question:

Which of the following agents has a black box warning?

a) Bisphosphonates

b) Denosumab

  • raloxifene (Correct answer)

Answer:

raloxifene (Correct answer) this agent is associated with an increased risk for venous thromboembolic events (e.g., deep vein thrombosis and PE) and death from stroke when given to postmenopausal women who have a history of or are at risk for coronary heart disease.

  • / 2

User Reviews

★★★★★ (5.0/5 based on 1 reviews)
Login to Review
S
Student
May 21, 2025
★★★★★

This document provided practical examples, which was incredibly useful for my research. Absolutely impressive!

Download Document

Buy This Document

$1.00 One-time purchase
Buy Now
  • Full access to this document
  • Download anytime
  • No expiration

Document Information

Category: QUESTIONS & ANSWERS
Added: Dec 16, 2025
Description:

Week 4 Midterm: NR565 / NR-565 (Latest Update) Advanced Pharmacology Fundamentals | Test Module Questions & Answers | 100% Correct | Grade A - Chamberlain Question: Marilyn has a bone density study...

Unlock Now
$ 1.00